POC Diagnostics Market Will Be Valued at $27.5 Billion in 2018 - New Research Report by MarketsandMarkets

Share Article

The global point-of-care diagnostics market is expected to reach $27.5 billion by 2018, at a CAGR of 9.3% from 2013 to 2018. http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html

MarketsandMarkets

MarketsandMarkets

Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (U.S.), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.)

The report “Point-Of-Care Diagnostics Market [(Products - Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), (End Users - Self & Professional Monitoring), (Over The Counter & Prescription Based)] – Global Forecast To 2018” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and the Rest of the World.

This report studies the global POC diagnostics market over the forecast period of 2013 to 2018. The market is poised to grow at a CAGR of 9.3% from 2013 to 2018, to reach $27.5 billion by 2018.

Do Inquire For Further Details at http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=106829185

In this report, the global POC diagnostics market has been segmented on the basis of category (infectious diseases testing kits, glucose monitoring kits, cardiac markers, pregnancy and fertility testing kits, and others) and end users (patient professional monitoring kits and patient self-monitoring kits). The glucose monitoring kits market held the largest share—53.7%—of the global POC diagnostics market in 2013, followed by the infectious diseases testing kits market. Factors such as rising global prevalence of diabetes, technological advancements in self-monitoring of blood glucose, and the growing patient awareness toward POC testing are stimulating the growth of the glucose monitoring kits market.

The fastest-growing segment—cardiac-markers market—is projected to grow at a CAGR of 15.3% from 2013 to 2018. This growth is mainly attributed to the increasing number of cardiac patients and the demand of immediate diagnosis of the diseases. Major players such as Roche (Switzerland), Abbott Laboratories, Inc. (U.S.), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.), and Alere Inc. (U.S.) are adopting several growth strategies such as new product launches, partnerships, agreements, collaborations, joint ventures, and mergers and acquisition in order to keep pace with the evolving industry trends in this market.

Geographically, North America commands the largest share of the global POC diagnostics market in 2013, followed by Europe. A number of factors such as increase in waiver of CLIA for certain point of care diagnostic tests, fostering FDA approvals for various immunoassay techniques, easy access to POC tests through diagnostic service providers, and presence of major leading companies are driving the growth of the POC diagnostics market in North America. However, the economic slowdown and unfavorable reimbursement scenario for tests due to government budget constraints the growth of the POC diagnostics market in this region. The Asia-Pacific region is poised to grow at the highest CAGR in the next five years. Factors such as huge patient population base, large number of R&D activities, and growing focus of both international and domestic players on the Asia-Pacific POC diagnostics market are propelling the growth of the POC diagnostic market in the Asia-Pacific region.

Speak to Analyst for More Details at http://www.marketsandmarkets.com/speaktoanalyst.asp?id=106829185

The global POC diagnostics market is highly competitive with a large number of global as well as local market players. As of 2012, the global POC diagnostics market excluding the blood glucose monitoring kits market was dominated by Roche (Switzerland), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.), which together accounted for ~72% of the market. As of 2012, the global blood glucose monitoring kits market was dominated by Roche Diagnostics Limited, Johnson & Johnson (J&J), Bayer AG, and Abbott Laboratories, Inc. These companies together accounted for a share of ~84% of the global blood glucose monitoring kits market. New product launches and partnerships/agreements/collaborations/joint ventures are the major strategies adopted by most market players to achieve growth in the POC diagnostics market.

Browse Related Reports:
Care Management Solutions Market by Component (Software & Services), Delivery Mode (On-premise, Web, & Cloud), End-user (Payer, Provider, Employer Groups, & Government Bodies) - Trends & Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/care-management-solutions-market-19482811.html

Companion Diagnostics Market byTechnology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical Companies, Reference Lab)] - Global Trends & Forecasts to 2019
http://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market-155571681.html

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog at http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn at http://www.linkedin.com/company/marketsandmarkets

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr. Rohan
Market Research Report
since: 12/2010
Like >
Follow us on
Visit website